Get the Stockscreener App
3.87
1.31%
0.05
Pre-market:
3.89
0.02
+0.52%
Black Diamond Therapeutics Inc stock is traded at $3.87, with a volume of 437.47K.
It is up +1.31% in the last 24 hours and up +2.11% over the past month.
Black Diamond Therapeutics Inc is a clinical-stage oncology company developing MasterKey therapies that target families of oncogenic mutations in patients with cancer. It is engaged in the discovery and development of small molecule, tumor-agnostic therapies. The company has one pipeline technology platform, namely Mutation-Allostery-Pharmacology, which is targeting mutations in cancer. Its drugs under the pipeline are BDTX-4933 and BDTX-1535.
See More
Previous Close:
$3.82
Open:
$3.82
24h Volume:
437.47K
Relative Volume:
0.48
Market Cap:
$220.34M
Revenue:
-
Net Income/Loss:
$-82.44M
P/E Ratio:
-2.0585
EPS:
-1.88
Net Cash Flow:
$-66.75M
1W Performance:
-1.53%
1M Performance:
+2.11%
6M Performance:
+127.65%
1Y Performance:
+41.24%
1-Day Range:
$3.78
$3.93
1-Week Range:
$3.71
$4.08
52-Week Range:
$1.195
$4.45
Black Diamond Therapeutics Inc Stock (BDTX) Company Profile
Name
Black Diamond Therapeutics Inc
Sector
Industry
Phone
617-417-5868
Address
ONE MAIN STREET, 14TH FLOOR, CAMBRIDGE, MA
Compare BDTX with other stocks
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
BDTX
Black Diamond Therapeutics Inc
|
3.87 | 217.49M | 0 | -82.44M | -66.75M | -1.88 |
|
VRTX
Vertex Pharmaceuticals Inc
|
425.57 | 107.66B | 11.39B | 3.64B | 3.50B | 13.99 |
|
REGN
Regeneron Pharmaceuticals Inc
|
651.80 | 68.74B | 14.25B | 4.58B | 3.88B | 41.77 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
456.04 | 58.93B | 3.21B | 43.57M | 221.36M | 0.2405 |
|
ARGX
Argen X Se Adr
|
818.50 | 50.51B | 3.06B | 1.28B | 447.35M | 19.67 |
|
INSM
Insmed Inc
|
189.60 | 41.29B | 447.02M | -1.18B | -868.57M | -6.1812 |
Black Diamond Therapeutics Inc Stock (BDTX) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| Oct-16-25 | Resumed | Stifel | Buy |
| Sep-04-25 | Initiated | Guggenheim | Buy |
| Jul-01-25 | Resumed | Raymond James | Outperform |
| Jul-31-24 | Initiated | Raymond James | Outperform |
| Jul-14-23 | Initiated | Piper Sandler | Overweight |
| Jun-30-23 | Upgrade | Stifel | Hold → Buy |
| Jun-28-23 | Upgrade | H.C. Wainwright | Neutral → Buy |
| Jun-27-23 | Upgrade | Wedbush | Neutral → Outperform |
| Mar-29-22 | Downgrade | Wedbush | Outperform → Neutral |
| Mar-22-22 | Downgrade | H.C. Wainwright | Buy → Neutral |
| Sep-30-21 | Initiated | Stifel | Hold |
| Jan-07-21 | Initiated | Wedbush | Outperform |
| Nov-24-20 | Initiated | Berenberg | Buy |
| May-04-20 | Initiated | H.C. Wainwright | Buy |
| Feb-24-20 | Initiated | Canaccord Genuity | Buy |
| Feb-24-20 | Initiated | Cowen | Outperform |
| Feb-24-20 | Initiated | JP Morgan | Overweight |
| Feb-24-20 | Initiated | Jefferies | Buy |
View All
Black Diamond Therapeutics Inc Stock (BDTX) Latest News
Tools to assess Black Diamond Therapeutics Inc.’s risk profileRate Hike & Low Drawdown Investment Strategies - newser.com
Is Black Diamond Therapeutics Inc. trending in predictive chart modelsJuly 2025 PostEarnings & Daily Price Action Insights - newser.com
Is Black Diamond Therapeutics Inc. building a consolidation baseWeekly Trade Review & Weekly Watchlist for Hot Stocks - newser.com
Real time scanner hits for Black Diamond Therapeutics Inc. explainedEarnings Trend Report & Real-Time Market Sentiment Alerts - newser.com
Can Black Diamond Therapeutics Inc. stock outperform in 2025 bull marketQuarterly Growth Report & Verified Short-Term Trading Plans - newser.com
Should You Buy, Hold, or Sell BDTX Stock Ahead of Q3 Earnings? - sharewise.com
Can Black Diamond Therapeutics Inc. stock resist market sell offsVolume Spike & Pattern Based Trade Signal System - newser.com
Volatility clustering patterns for Black Diamond Therapeutics Inc.Quarterly Portfolio Report & Daily Volume Surge Signals - newser.com
How geopolitical tensions affect Black Diamond Therapeutics Inc. stockJuly 2025 EndofMonth & Fast Entry High Yield Stock Tips - newser.com
Using fundamentals and technicals on Black Diamond Therapeutics Inc.Earnings Overview Summary & Free High Return Stock Watch Alerts - newser.com
Chart based exit strategy for Black Diamond Therapeutics Inc.2025 Historical Comparison & Smart Investment Allocation Tips - newser.com
What analysts say about Black Diamond Therapeutics Inc stockGrowth vs. Value Investing & Free Get High Impact Recommendations - earlytimes.in
Black Diamond Therapeutics (BDTX) Projected to Post Quarterly Earnings on Tuesday - MarketBeat
Published on: 2025-10-27 19:48:31 - newser.com
Published on: 2025-10-26 22:14:09 - newser.com
Black Diamond Therapeutics Inc Stock (BDTX) Financials Data
Revenue
Net Income
Cash Flow
EPS
1.62%
0.21%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):